Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Lancet Neurology

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1474-4422(12)70309-5PMID 23332363PMCID PMC3690378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low relative humidity triggers RNA-directed de novo DNA methylation and suppression of genes controlling stomatal development

  2012cited by this paper
• Histone methylation: a dynamic mark in health, disease and inheritance

  2012influential reference
• Distinct DNA methylomes of newborns and centenarians

  2012cited by this paper
• The interplay between the intestinal microbiota and the brain

  2012cited by this paper
• MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers.

  2012cited by this paper
• Molecular mechanisms and potential functions of histone demethylases

  2012influential reference
• Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation

  2012cited by this paper
• The microbiome in infectious disease and inflammation.

  2012cited by this paper
• New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?

  2012cited by this paper
• The genetics of multiple sclerosis: an up‐to‐date review

  2012cited by this paper
• Regulated microRNAs in the CSF of patients with multiple sclerosis

  2012cited by this paper
• Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

  2012cited by this paper
• An Integrated Encyclopedia of DNA Elements in the Human Genome

  2012cited by this paper
• Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease

  2012cited by this paper
• Impaired adult myelination in the prefrontal cortex of socially isolated mice

  2012cited by this paper
• The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression

  2012cited by this paper
• Adhesive Properties and Inflammatory Potential of Citrullinated Myelin Basic Protein Peptide 45–89

  2012cited by this paper
• Environmentally coordinated epigenetic silencing of FLC by protein and long noncoding RNA components.

  2012cited by this paper
• Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells

  2012cited by this paper
• Circulating microRNAs involved in multiple sclerosis

  2012cited by this paper
• Exploring the role of the epigenome in multiple sclerosis: a window onto cell-specific transcriptional potential.

  2012cited by this paper
• Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes

  2012cited by this paper
• Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis.

  2011cited by this paper
• Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients

  2011cited by this paper
• The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.

  2011cited by this paper
• Gene silencing by microRNAs: contributions of translational repression and mRNA decay

  2011cited by this paper
• Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis

  2011cited by this paper
• Non-Coding RNAs in Neural Networks, REST-Assured

  2011cited by this paper
• Uncovering the role of 5-hydroxymethylcytosine in the epigenome

  2011cited by this paper
• Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

  2011cited by this paper
• Changed Histone Acetylation Patterns in Normal-Appearing White Matter and Early Multiple Sclerosis Lesions

  2011cited by this paper
• ATP-dependent chromatin remodeling: genetics, genomics and mechanisms

  2011cited by this paper
• Tobacco-smoking-related differential DNA methylation: 27K discovery and replication.

  2011cited by this paper
• Non-coding RNAs in human disease

  2011cited by this paper
• Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects.

  2011cited by this paper
• Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation.

  2011cited by this paper
• CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing

  2011cited by this paper
• Histone arginine methylation

  2011cited by this paper
• NeurimmiRs: microRNAs in the neuroimmune interface.

  2011cited by this paper
• Histone variant macroH2A confers resistance to nuclear reprogramming

  2011cited by this paper
• Revealing the genetic basis of multiple sclerosis: are we there yet?

  2011cited by this paper
• Allele-specific transcriptional elongation regulates monoallelic expression of the IGF2BP1 gene

  2011cited by this paper
• A Peek into the Complex Realm of Histone Phosphorylation

  2011influential reference
• Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.

  2011cited by this paper
• A unique H2A histone variant occupies the transcriptional start site of active genes

  2011cited by this paper
• HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells

  2011cited by this paper
• Epigenetic Modifiers Are Necessary but Not Sufficient for Reprogramming Non-Myelinating Cells into Myelin Gene-Expressing Cells

  2010cited by this paper
• Epigenetic control of neural precursor cell fate during development

  2010cited by this paper
• Environmental factors and their timing in adult-onset multiple sclerosis

  2010cited by this paper
• A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

  2010cited by this paper
• MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood

  2010cited by this paper
• The histone variant macroH2A suppresses melanoma progression through regulation of CDK8

  2010cited by this paper
• Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis

  2010cited by this paper
• Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.

  2010cited by this paper
• Altered miRNA expression in T regulatory cells in course of multiple sclerosis.

  2010cited by this paper
• Epigenetic regulation of oligodendrocyte identity.

  2010cited by this paper
• Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients

  2010cited by this paper
• Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice

  2010cited by this paper
• Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency

  2010cited by this paper
• Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

  2010cited by this paper
• Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals.

  2010cited by this paper
• Multiple sclerosis: risk factors, prodromes, and potential causal pathways

  2010cited by this paper
• Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes

  2010cited by this paper
• Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• MicroRNA-mediated control of oligodendrocyte differentiation.

  2010cited by this paper
• Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination.

  2010cited by this paper
• Active DNA demethylation mediated by DNA glycosylases.

  2009cited by this paper
• MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

  2009cited by this paper
• Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury.

  2009cited by this paper
• Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

  2009cited by this paper
• Functional Connection between Deimination and Deacetylation of Histones

  2009cited by this paper
• Folic acid, methylation and neural tube closure in humans.

  2009cited by this paper
• Timing of Birth and Risk of Multiple Sclerosis in the Scottish Population

  2009cited by this paper
• Body size and risk of MS in two cohorts of US women

  2009cited by this paper
• HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage

  2009cited by this paper
• HDAC1 and HDAC2 Regulate Oligodendrocyte Differentiation By Disrupting β-Catenin-TCF Interaction

  2009cited by this paper
• The biology of chromatin remodeling complexes.

  2009cited by this paper
• Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression

  2009cited by this paper
• H2A.Bbd: an X-chromosome-encoded histone involved in mammalian spermiogenesis

  2009cited by this paper
• INCIDENTAL MRI ANOMALIES SUGGESTIVE OF MULTIPLE SCLEROSIS: THE RADIOLOGICALLY ISOLATED SYNDROME

  2009cited by this paper
• Incidental MRI anomalies suggestive of multiple sclerosis

  2009cited by this paper
• RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells.

  2009cited by this paper
• Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury

  2009cited by this paper
• MicroRNA in autoimmunity and autoimmune diseases.

  2009cited by this paper
• MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

  2009cited by this paper
• Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients

  2009cited by this paper
• Increasing prevalence and incidence of multiple sclerosis in South East Wales

  2008cited by this paper
• Combinatorial patterns of histone acetylations and methylations in the human genome

  2008influential reference
• Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPARα promoter of the offspring

  2008cited by this paper
• Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks

  2008cited by this paper
• Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

  2008cited by this paper
• Environmental factors and multiple sclerosis.

  2008cited by this paper
• Histone ubiquitination: triggering gene activity.

  2008cited by this paper
• Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes

  2008cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• Genome-wide maps of chromatin state in pluripotent and lineage-committed cells

  2007cited by this paper
• Phenotypic plasticity and the epigenetics of human disease

  2007cited by this paper
• Sirtuins in mammals: insights into their biological function.

  2007cited by this paper
• Higher-order structures of chromatin: the elusive 30 nm fiber.

  2007cited by this paper
• The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation.

  2007cited by this paper

• Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models.

  2026cites this paper
• miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

  2026cites this paper
• Obesity, Nutrition and the Multiple Sclerosis Risk in Adolescents

  2026cites this paper
• Epigenetic Modulation of Immunity: Mechanisms, Implications, and Emerging Therapeutic Horizons; a Step Toward Epigenetics to Precision.

  2026cites this paper
• G-Quadruplex and i-Motif Structures in the SHMT1 5’UTR Modulate Gene Expression

  2025cites this paper
• Beyond the genome: epigenetic regulation of immune responses and T cells in brain tumors

  2025cites this paper
• Molecular Biomarkers in Neurological Diseases: Advances in Diagnosis and Prognosis

  2025cites this paper
• Elevated Oxidative Stress in Patients with Coexisting Multiple Sclerosis and Migraine: A Cross-Sectional Study

  2025cites this paper
• MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis

  2025cites this paper
• Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers

  2025cites this paper
• Genomic, Epigenomic, and Immuno-Genomic Regulations of Vitamin D Supplementation in Multiple Sclerosis: A Literature Review and in Silico Meta-Analysis

  2025cites this paper
• Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA‐DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset

  2025cites this paper
• Pathogenic synergy: dysfunctional mitochondria and neuroinflammation in neurodegenerative diseases associated with aging

  2025cites this paper
• Exploring the potential causal association between genetic factors for multiple sclerosis and genetic factors for kidney disease: A multivariate Mendelian randomization study

  2025cites this paper
• Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis

  2025cites this paper
• Current state and perspectives of CAR T cell therapy in central nervous system diseases.

  2024cites this paper
• A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis

  2024cites this paper
• Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms

  2024cites this paper
• Revisiting the critical roles of reactive astrocytes in neurodegeneration

  2023cites this paper
• Epigenetics as a versatile regulator of fibrosis

  2023cites this paper
• Multiple Sclerosis: Inflammatory and Neuroglial Aspects

  2023cites this paper
• Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments

  2023cites this paper
• The stability of the myelinating oligodendrocyte transcriptome is regulated by the nuclear lamina

  2023cites this paper
• Global DNA Methylation and Hydroxymethylation Levels in PBMCs Are Altered in RRMS Patients Treated with IFN-β and GA—A Preliminary Study

  2023cites this paper
• Tyrosine Kinases: Targets for Epigenetic Influences and a New Direction in the Treatment of Multiple Sclerosis

  2023cites this paper
• Targeting epigenetic modifications in Parkinson's disease therapy

  2023cites this paper
• Epigenotoxicity: a danger to the future life

  2023cites this paper
• Cancer epigenetics: Chromatin remodeling and other epigenetic mechanisms

  2022cites this paper
• Function and therapeutic value of astrocytes in neurological diseases

  2022cites this paper
• Multiple Sclerosis and Autoimmunity: A Veiled Relationship

  2022cites this paper
• Epigenetics in Alzheimer’s Disease

  2022cites this paper
• G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis

  2022cites this paper
• miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis

  2022cites this paper
• Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure

  2022cites this paper
• Association between forkhead box P3 expression level and gender of Iranian juvenile idiopathic arthritis patients

  2022cites this paper
• TET1-mediated DNA hydroxymethylation regulates adult remyelination in mice

  2021cites this paper
• The expression and prognostic value of miR-146a and miR-155 in Turkish patients with multiple sclerosis

  2021cites this paper
• Cannabinoids and Neuropsychiatric Disorders

  2021cites this paper
• The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls.

  2020cites this paper
• The emerging role of lncRNAs in multiple sclerosis.

  2020cites this paper
• Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas

  2020cites this paper
• Epigenetic aspects of multiple sclerosis and future therapeutic options

  2020cites this paper
• Environmental Influencers, MicroRNA, and Multiple Sclerosis

  2020cites this paper
• Peripheral nerve injury and myelination: Potential therapeutic strategies

  2020cites this paper
• Molecular mimicry between Zika virus and central nervous system inflammatory demyelinating disorders: the role of NS5 Zika virus epitope and PLP autoantigens

  2020cites this paper
• Cannabinoid-Based Medicines and Multiple Sclerosis.

  2020cites this paper
• Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

  2020cites this paper
• The epigenetics of multiple sclerosis

  2019cites this paper
• Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis

  2019cites this paper
• Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis.

  2019cites this paper
• DNA hydroxymethylation changes in response to spinal cord damage in a multiple sclerosis mouse model.

  2019cites this paper
• The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis

  2019influential citation
• Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis.

  2019cites this paper
• The Epigenetic Machinery in the Life Cycle and Pharmacoepigenetics

  2019cites this paper
• Pharmacoepigenetics of Vertigo and Related Vestibular Syndromes

  2019cites this paper
• Understanding the Role of Androgen Receptor Signaling in Modulating p38-alpha Mitogen-Activated Protein Kinase in Experimental Autoimmune Encephalomyelitis

  2019cites this paper
• Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• Epigenetic modifications in brain and immune cells of multiple sclerosis patients

  2018cites this paper
• The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency

  2018influential citation
• Smoking at time of CIS increases the risk of clinically definite multiple sclerosis

  2018cites this paper
• Epigenetic mechanisms in pathogenesis of multiple sclerosis

  2018cites this paper
• The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases

  2018cites this paper
• Analyse von Polymorphismen in Genen von RIG-I-like Rezeptoren in deutschen Multiple Sklerose Patienten und Untersuchungen zur familiären Multiplen Sklerose

  2018influential citation
• Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis

  2018cites this paper
• The tale of histone modifications and its role in multiple sclerosis

  2018cites this paper
• Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1

  2018cites this paper
• Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

  2018cites this paper
• Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.

  2018cites this paper
• Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis

  2018cites this paper
• Role of intestinal microbiota in the development of multiple sclerosis

  2017cites this paper
• DNA methylation in demyelinated multiple sclerosis hippocampus

  2017cites this paper
• Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

  2017influential citation
• Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view

  2017cites this paper
• Epigenetic Modifications and Therapy in Multiple Sclerosis

  2017cites this paper
• The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard ‘Dick’ T. Johnson

  2017cites this paper
• Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients.

  2017cites this paper
• Epigenetic changes in neurology: DNA methylation in multiple sclerosis

  2017cites this paper
• Epigenetics, Stem Cells, Cellular Differentiation, and Associated Hereditary Neurological Disorders

  2017influential citation
• Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.

  2017cites this paper
• Fast multiple sclerosis progression in North Africans

  2017cites this paper
• [Gut human microbiota and multiple sclerosis].

  2017cites this paper
• The genetics of multiple sclerosis in Latin America

  2017cites this paper
• Involvement of epigenetic mechanisms in disease inheritance and pathogenesis of Multiple Sclerosis (MS) with a focus on genomic imprinting and DNA methylation in CD4+ T cells

  2017cites this paper
• Epigenetic Changes in DNA Methylation and Environment in Multiple Sclerosis

  2017cites this paper
• Role of intestinal microbiota in the development of multiple sclerosis.

  2017cites this paper
• Epigenetic changes in neurology: DNA methylation in multiple sclerosis.

  2017cites this paper
• MicroRNAs (20a, 146a, 155, and 145) expressions in a sample of Iraqi patients with multiple sclerosis

  2016cites this paper
• Chapter 32 – Pharmacoepigenomics

  2016cites this paper
• Epigenetic Drugs for Multiple Sclerosis

  2016cites this paper
• Repetitive element hypermethylation in multiple sclerosis patients

  2016cites this paper
• The Role of Over-Nutrition and Obesity in Multiple Sclerosis

  2016influential citation
• Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

  2016cites this paper
• Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review.

  2016cites this paper
• Epigenetic Mechanisms in Sjögren’s Syndrome

  2016cites this paper
• Genome-Wide Epigenetic Studies in Neurologic Diseases

  2016cites this paper
• The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences

  2016cites this paper
• Expression and regulation of human endogenous retrovirus W elements

  2016cites this paper
• Further understanding of the immunopathology of multiple sclerosis: impact on future treatments

  2016cites this paper
• Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches

  2016cites this paper
• New Strategies in Multiple Sclerosis Therapy International Journal of Autoimmune Disorders & Therapy

  2016cites this paper